Donald S. Baim, MD, Executive Vice President, Chief Medical and Scientific Officer, Boston Scientific Corporation; Natick, Massachusetts
Donald S. Baim, MD, Executive Vice Pr...
The Impact of DES
Since their introduction in 2003, drug-eluting stents (DES) have shown clear and substantial benefits in patients with coronary artery disease. Compared to their predecessors, bare-metal stents (BMS), DES reduce rates of...
The Impact of DES
Since their introduction in 2003, drug-eluting stents (DES) have shown clear and substantial benefits in patients with coronary artery disease. Compared to their predecessors, bare-metal stents (BMS), DES reduce rates of...
The Impact of DES
Since their...